Navigation Links
Mannatech to Begin Selling Nutritional Supplements in South Africa
Date:2/26/2008

New operation to launch in second quarter of 2008

COPPELL, Texas, Feb. 26 /PRNewswire-FirstCall/ -- Mannatech, Incorporated (Nasdaq: MTEX), a leading developer and provider of dietary supplements and skin care solutions, announced today it will begin selling products in South Africa during the second quarter of this year.

Among these products will be the company's Optimal Health System, which is comprised of Ambrotose -- a patented blend of mixed plant saccharides; AO -- a proprietary antioxidant; PLUS -- an herbal-amino acid; and PhytoMatrix -- the industry's first all-natural multivitamin with concentrated, plant-sourced minerals and standardized phytochemicals.

"We are excited to enter the market in South Africa, which was the first country to grant a patent for the technology related to the formulation of Mannatech's flagship product, Ambrotose," said Mannatech President and CEO Terry Persinger. "South Africa has a rich tradition of using nature's biodiversity to help address quality of life and optimal health. This tradition aligns well with Mannatech products and our emphasis on natural ingredients."

About Mannatech

Mannatech, Incorporated, is a global wellness solutions provider of innovative, high-quality, proprietary nutritional supplements, topical and skin care products, and weight management products sold through independent associates and members located in the United States and the international markets of Canada, Australia, the United Kingdom, Japan, New Zealand, the Republic of Korea, Taiwan, Denmark, and Germany.

Please Note: This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as "intend" or other similar words or the negative of such terminology. Similarly, descriptions of Mannatech's objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Mannatech believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties, and other factors. Some of these factors include, among others, Mannatech's inability to attract and retain associates and members, increases in competition, litigation, regulatory changes, and its planned growth into new international markets. Although Mannatech believes that the expectations, statements, and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.

Contact Information:

Gary Spinell, Vice President

Investor Relations

972-471-6512

ir@mannatech.com

Corporate website: http://www.mannatech.com


'/>"/>
SOURCE Mannatech, Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Mannatech Names New VP of Regulatory Affairs, Quality Assurance
2. Mannatech to Open Centralized-Management Office in Switzerland
3. Mannatech Hosts Australasian Convention
4. Mannatech Hosts Japan National Convention
5. Mannatech Launches Phase One of New Sales and Training Tools
6. PLC Systems Files IDE Supplement to Begin Pivotal Study of RenalGuard(TM) and Provides Update on Planned Development Timeline
7. XTend Medical (XMDC) Begins Remote Diabetic Telehealth Program
8. Hondros College Expands School of Nursing to Columbus and Dayton; Students Can Begin LPN Education Almost Immediately
9. High blood pressure worsening in all states for women; begins to stagnate for men
10. Parental Alienation Awareness Organization Begins Preparations for Parental Alienation Awareness Day - April 25th
11. A New Beginning for Medicare Beneficiaries in North Carolina
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm ... sciences executive with extensive sequencing and genomics experience, as Vice President of North American ... Hill will be responsible for leading the sales team in the commercialization of the ...
(Date:6/24/2016)... ... June 24, 2016 , ... Today, MTI-GlobalStem, a provider ... and other difficult to transfect cells, announces its launch of the PluriQ™ G9™ ... Editing System is a complete system for culturing and transfecting human pluripotent ...
(Date:6/24/2016)... Palm City, FL (PRWEB) , ... June 24, 2016 , ... ... and inflammation common after venous procedures, dermaka cream can be incorporated into the post-surgical ... peels, and minor surgical procedures. , dermaka cream is very effective for bruising ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Randall Markarian, DDS, are co-chairs for the Illinois State Dental Society (ISDS) ... July 15-16 at the Gateway Convention Center in Collinsville. , They ...
(Date:6/24/2016)... ... June 24, 2016 , ... SpiritQuest Sedona Retreats, located ... West Sedona, surrounded by famous vortex sites: Cathedral Rock, Airport Mesa, and Boynton Canyon. ... – the Lodge at Sedona as well as the Sedona Rouge, both popular accommodations ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
(Date:6/23/2016)... , June 23, 2016 Research ... Pharma News Issue 52" report to their offering. ... in influenza treatment creates a favourable commercial environment for MedImmune ... growing patient base that will serve to drive considerable growth ... vaccine would serve to cap sales considerably, but development is ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 If ... Leaders Scholarship is any indication, the future is in ... at www.diabetesscholars.org by the Diabetes Scholars Foundation ... the way of academic and community service excellence. ... since 2012, and continues to advocate for people with ...
Breaking Medicine Technology: